From the Research
NovoMix (biphasic insulin aspart) is typically administered in a range of 1 to 60 units per injection, with the specific dosage depending on individual patient factors such as blood glucose levels, weight, diet, activity level, and other medications. The dosage of NovoMix can be adjusted in 1-unit increments using insulin pens or syringes, allowing for fine-tuned control over blood glucose levels.
- The combination of rapid-acting insulin aspart and intermediate-acting insulin aspart protamine in NovoMix provides both immediate glucose control after meals and background insulin coverage between meals.
- Patients should follow their healthcare provider's specific dosing instructions, as insulin requirements can vary significantly between individuals and may change over time due to factors such as illness, stress, or changes in diet and physical activity 1. Key considerations for NovoMix dosing include:
- Starting with a low dose and gradually increasing as needed to minimize the risk of hypoglycemia
- Adjusting the dose based on blood glucose monitoring results and other factors such as meal times and physical activity
- Using the pen delivery devices to allow for precise dosing in 1-unit increments
- Regularly reviewing and adjusting the dosing regimen as needed to maintain optimal blood glucose control.